Compare ANET & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANET | LLY |
|---|---|---|
| Founded | 2004 | 1876 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 168.2B | 950.7B |
| IPO Year | 2014 | N/A |
| Metric | ANET | LLY |
|---|---|---|
| Price | $130.01 | $1,040.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 19 |
| Target Price | $163.93 | ★ $1,104.11 |
| AVG Volume (30 Days) | ★ 6.7M | 2.7M |
| Earning Date | 02-17-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 0.67% |
| EPS Growth | 26.15 | ★ 121.02 |
| EPS | 2.63 | ★ 20.44 |
| Revenue | $8,448,346,000.00 | ★ $59,419,800,000.00 |
| Revenue This Year | $29.46 | $42.97 |
| Revenue Next Year | $21.86 | $21.50 |
| P/E Ratio | ★ $49.66 | $50.53 |
| Revenue Growth | 27.75 | ★ 45.41 |
| 52 Week Low | $59.43 | $623.78 |
| 52 Week High | $164.94 | $1,133.95 |
| Indicator | ANET | LLY |
|---|---|---|
| Relative Strength Index (RSI) | 50.40 | 46.08 |
| Support Level | $120.00 | $1,012.57 |
| Resistance Level | $133.34 | $1,090.22 |
| Average True Range (ATR) | 4.67 | 31.46 |
| MACD | -0.02 | -7.31 |
| Stochastic Oscillator | 46.10 | 21.70 |
Arista Networks is a networking equipment provider that primarily sells Ethernet switches and software to data centers. Its marquee product is its extensible operating system, or EOS, that runs a single image across every single one of its devices. The firm operates as one reportable segment. It has steadily gained market share since its founding in 2004, with a focus on high-speed applications. Arista counts Microsoft and Meta Platforms as its largest customers and derives roughly three quarters of its sales from North America.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.